Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II studyYan Gao, Huiqiang Huang|Signal Transduction and Targeted Therapy|2024Cited by 32